BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19687593)

  • 1. Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib.
    Tsuzuki M; Inaguma Y; Handa K; Hasegawa A; Yamamoto Y; Watanabe M; Mizuta S; Maruyama F; Okamoto M; Emi N
    Intern Med; 2009; 48(16):1433-5. PubMed ID: 19687593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
    Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
    Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.
    Skoumalova I; Vondrakova J; Rohon P; Rozmanova S; Jarosova M; Indrak K; Prochazka M; Santava A; Faber E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):121-3. PubMed ID: 18795086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome of two patients treated with imatinib.
    Prabhash K; Sastry PS; Biswas G; Bakshi A; Prasad N; Menon H; Parikh PM
    Ann Oncol; 2005 Dec; 16(12):1983-4. PubMed ID: 16100234
    [No Abstract]   [Full Text] [Related]  

  • 5. Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy.
    Mukhopadhyay A; Dasgupta S; Kanti Ray U; Gharami F; Bose CK; Mukhopadhyay S
    Ir J Med Sci; 2015 Mar; 184(1):183-8. PubMed ID: 24590821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib.
    Heartin E; Walkinshaw S; Clark RE
    Leuk Lymphoma; 2004 Jun; 45(6):1307-8. PubMed ID: 15360020
    [No Abstract]   [Full Text] [Related]  

  • 7. Pregnancy in patients with chronic myeloid leukemia treated with imatinib.
    Yilmaz M; Demirhan O; Kuçukosmanoglu E; Pehlivan M; Okan V; Balat O; Pehlivan S
    Leuk Lymphoma; 2007 Dec; 48(12):2454-6. PubMed ID: 18067024
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia.
    Simonsson B; Gedde-Dahl T; Markevärn B; Remes K; Stentoft J; Almqvist A; Björeman M; Flogegård M; Koskenvesa P; Lindblom A; Malm C; Mustjoki S; Myhr-Eriksson K; Ohm L; Räsänen A; Sinisalo M; Själander A; Strömberg U; Bjerrum OW; Ehrencrona H; Gruber F; Kairisto V; Olsson K; Sandin F; Nagler A; Nielsen JL; Hjorth-Hansen H; Porkka K;
    Blood; 2011 Sep; 118(12):3228-35. PubMed ID: 21685374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy on imatinib: fatal outcome with meningocele.
    Choudhary DR; Mishra P; Kumar R; Mahapatra M; Choudhry VP
    Ann Oncol; 2006 Jan; 17(1):178-9. PubMed ID: 16291579
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
    Buyukbayrak EE; Ergen B; Karsidag YK; Kars B; Turan C; Argon D
    Arch Gynecol Obstet; 2008 Aug; 278(2):161-3. PubMed ID: 18193246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay.
    Pavlovsky C; Giere I; Moiraghi B; Pavlovsky MA; Aranguren PN; García J; Fernandez I; Bengió R; Milone J; Labanca V; Uriarte R; Lombardi V; Reinoso FG; Magariños AE; Martinez L; Murro H; Lastiri F; Pavlovsky S
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):280-5. PubMed ID: 21658656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib.
    Garderet L; Santacruz R; Barbu V; van den Akker J; Carbonne B; Gorin NC
    Haematologica; 2007 Jan; 92(1):e9-10. PubMed ID: 17405743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myeloid leukemia in children and adolescents: results of treatment with imatinib mesylate.
    Lakshmaiah KC; Bhise R; Purohit S; Abraham LJ; Lokanatha D; Suresh TM; Appaji L; Arunakumari BS; Govindbabu K
    Leuk Lymphoma; 2012 Dec; 53(12):2430-3. PubMed ID: 22607062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester.
    Suppiah R; Kalaycio M
    Leuk Lymphoma; 2006 Jun; 47(6):1149-50. PubMed ID: 16840209
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature.
    Cole S; Kantarjian H; Ault P; Cortés JE
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):324-7. PubMed ID: 19717385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disease transformation in imatinib mesylate treated Philadelphia chromosome-positive chronic myelogenous leukemia patients achieved cytogenetic remissions].
    Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Lu DP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):612-5. PubMed ID: 16378113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular monitoring of response to imatinib (Glivec) in chronic myeloid leukemia patients: experience at a tertiary care hospital in Saudi Arabia.
    Khalil SH; Abu-Amero KK; Al Mohareb F; Chaudhri NA
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):67-74. PubMed ID: 19943786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
    Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J
    J Clin Oncol; 2006 Mar; 24(7):1204-8. PubMed ID: 16446320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
    Wang DP; Liang MY; Zhang XH; Wang SM
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful delivery after planned discontinuation of imatinib in a patient with chronic myeloid leukemia.
    Kobayashi K; Takebayashi C; Miyata S; Narimatsu H; Kami M
    Intern Med; 2009; 48(5):369-71. PubMed ID: 19252364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.